Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
PPAR α antagonist
DRUG CLASS:
PPAR α antagonist
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
TPST-1120 (4)
TPST-1120 (4)
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
TIGIT underexpression
Solid Tumor
TIGIT underexpression
Solid Tumor
TPST-1120
Sensitive: C3 – Early Trials
TPST-1120
Sensitive
:
C3
TPST-1120
Sensitive: C3 – Early Trials
TPST-1120
Sensitive
:
C3
APOE overexpression
Solid Tumor
APOE overexpression
Solid Tumor
TPST-1120
Sensitive: C3 – Early Trials
TPST-1120
Sensitive
:
C3
TPST-1120
Sensitive: C3 – Early Trials
TPST-1120
Sensitive
:
C3
PVR underexpression
Solid Tumor
PVR underexpression
Solid Tumor
TPST-1120
Sensitive: C3 – Early Trials
TPST-1120
Sensitive
:
C3
TPST-1120
Sensitive: C3 – Early Trials
TPST-1120
Sensitive
:
C3
RORC overexpression
Solid Tumor
RORC overexpression
Solid Tumor
TPST-1120
Sensitive: C3 – Early Trials
TPST-1120
Sensitive
:
C3
TPST-1120
Sensitive: C3 – Early Trials
TPST-1120
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login